Orbis Allan Gray Ltd
- SEC CIK
- 0001663865
- Latest filing
- Aug 14, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Orbis Allan Gray Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,449,161
- Value
- $297.2M
- % of portfolio
- 1.0%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,449,161 | $297.2M | 1.0% | −656,850−10.8% | Reduced | Holders |
| Q1 2026 | 6,106,011 | $290.5M | 1.2% | +155,866+2.6% | Added | Holders |
| Q4 2025 | 5,950,145 | $312.0M | 1.3% | +968,060+19.4% | Added | Holders |
| Q3 2025 | 4,982,085 | $322.9M | 1.4% | +2,217,553+80.2% | Added | Holders |
| Q2 2025 | 2,764,532 | $134.5M | 0.7% | +1,201,600+76.9% | Added | Holders |
| Q1 2025 | 1,562,932 | $53.2M | 0.3% | +86,813+5.9% | Added | Holders |
| Q4 2024 | 1,476,119 | $58.1M | 0.3% | +1,476,119 | New | Holders |